Aggressive LDL-C Lowering and the Brain: Impact on Risk for
![](https://professional.heart.org/-/media/PHD-Images/Science-News/p/puzzle_head_750x500.jpg)
![](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00151/article_deploy/html/images/pharmaceuticals-15-00151-g001.png?1643262731)
Pharmaceuticals, Free Full-Text
Colin Gimblet on LinkedIn: Had a great time at the North American Artery conference this past…
![](https://drhoffman.com/wp-content/uploads/2022/12/is_cholestrolillustration_sh.jpg)
Are cholesterol drugs bad for the brain?
![](https://www.mdpi.com/biomedicines/biomedicines-10-00970/article_deploy/html/images/biomedicines-10-00970-g001.png)
Biomedicines, Free Full-Text
![](https://www.medrxiv.org/content/medrxiv/early/2022/03/23/2022.03.22.22272697/F4.large.jpg)
Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk
![](https://www.ahajournals.org/cms/asset/47c93fbe-3ccb-45df-9dec-f199024ebc2c/strokeaha.121.034576.fig06.jpg)
Lipid-Lowering Therapy and Hemorrhagic Stroke Risk
![](https://i0.wp.com/nourishedbyscience.com/wp-content/uploads/2023/12/Slides.key-blood-lipid-measures-3_Nov-29-2023.png?fit=800%2C450&ssl=1)
Blood Lipids and Cardiovascular Risk: Everything You Need to Know - Nourished by Science
Eugenia Gianos la ut et innlegg på LinkedIn
Effects of LDL-C lowering drugs or genetic variants on glucose
![](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-24153-1/MediaObjects/41598_2022_24153_Fig1_HTML.png)
Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
![](https://www.archivesofmedicalscience.com/f/fulltexts/145970/AMS-18-4-145970-g006.jpg)
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)
![](https://www.jacc.org/cms/asset/032e35c2-9d5e-47d5-aca2-465be53c01f1/ga1.jpg)
Lipoprotein(a): A Residual Cardiovascular Risk Factor in Statin-Treated Stroke Survivors: Insights From the SPARCL Trial
![](https://ars.els-cdn.com/content/image/1-s2.0-S2095927321001316-gr1.jpg)
Low levels of low-density lipoprotein cholesterol and cognitive decline - ScienceDirect